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A B S T R A C T
The study of male and female reproductive tract development requires expertise in two separate disciplines,
developmental biology and endocrinology. For ease of experimentation and economy, the mouse has been used
extensively as a model for human development and pathogenesis, and for the most part similarities in devel-
opmental processes and hormone action provide ample justification for the relevance of mouse models for
human reproductive tract development. Indeed, there are many examples describing the phenotype of human
genetic disorders that have a reasonably comparable phenotype in mice, attesting to the congruence between
mouse and human development. However, anatomic, developmental and endocrinologic differences exist be-
tween mice and humans that (1) must be appreciated and (2) considered with caution when extrapolating
information between all animal models and humans. It is critical that the investigator be aware of both the
similarities and differences in organogenesis and hormone action within male and female reproductive tracts so
as to focus on those features of mouse models with clear relevance to human development/pathology. This
review, written by a team with extensive expertise in the anatomy, developmental biology and endocrinology of
both mouse and human urogenital tracts, focusses upon the significant human/mouse differences, and when
appropriate voices a cautionary note regarding extrapolation of mouse models for understanding development of
human male and female reproductive tracts.
1. Introduction
Developmental biologists have employed a range of species (fish,
amphibians, birds and mammals) to decipher that morphogenetic and
molecular processes involved in vertebrate development with the un-
derlying view that animal models may reveal human developmental
mechanisms and provide an understanding of congenital birth defects.
The literature is replete with numerous examples of the value of animal
models and their relevance to human development. Embryonic, fetal
and neonatal mice have been extensively used to study organogenesis
and differentiation with the tacit assumption that morphogenetic and
molecular mechanisms in mice are congruent with human develop-
ment. This belief is fostered by many developmental features shared in
common by mice and humans. Both species have, with few exceptions,
the same spectrum of organs and numerous developmental processes
that appear similar if not identical. Also, many genetic disorders in
humans have direct counterparts in spontaneously mutant or geneti-
cally manipulated mice. For example, a fundamentally similar femin-
ized phenotype is seen (a) in androgen-insensitive XTfm/Y mice, (b) in
genetically engineered androgen-receptor-deficient mice, and (c) in
humans with genetically defective androgen receptor (Ohno, 1979;
Walters et al., 2010; Wilson, 1987; Yeh et al., 2002).
Androgens play a central role in masculine development in both
rodents and humans as is the role/function of Müllerian inhibiting
substance in determining the fate of the Müllerian ducts (Cunha et al.,
2019b; MacLaughlin and Donahoe, 2002; Ren et al., 2017; Wilson et al.,
1981). Tissue recombinant experiments illustrate the concurrence be-
tween rodent and human developmental mechanisms in so far as mouse
(or rat) urogenital sinus mesenchyme (UGM, prostatic inductor) in-
duces human urinary bladder epithelium to form prostate-like glands
that produce human prostate specific antigen (Aboseif et al., 1999;
Cunha et al., 1983). The implication of this experiment is that the
signaling molecules constituting the dialogue of prostatic mesench-
ymal-epithelial interactions are sufficiently conserved that mouse and
rat UGM can reprogram human epithelial morphogenesis and differ-
entiation.
While the above findings favor the relevance of mouse studies for
human biology, critical comparisons of mouse versus human
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development reveal morphogenetic and anatomical differences. One
factor hampering such human/mouse comparisons is the limited lit-
erature on human organogenesis, particularly in regard to molecular
mechanisms. Also, the technical sophistication of decades-old studies
on human organogenesis rests in many cases on histologic examination
and to a much limited extent on modern molecular techniques.
Extrapolation of mouse models to human development requires ex-
pertise of the fine points of both mouse and human organogenesis. The
sobering fact is that certain aspects of mouse and human reproductive
tract development are fundamentally different and thus must be criti-
cally examined for relevance to human developmental biology. This
review focuses on mouse/human developmental and anatomical dif-
ferences and their implications vis a vie human biology/pathology.
2. Preputial development
Adult anatomy represents the endpoint of highly orchestrated de-
velopmental processes, and accordingly adult anatomic differences
between mice and humans are indicative of differences in morphoge-
netic and molecular mechanisms of development. Mice have two pre-
puces, while humans have only one prepuce (Fig. 1A–B) (Blaschko
et al., 2013). Male mice have an external prepuce that constitutes the
prominent perineal appendage (Fig. 1C) (Sinclair et al., 2016c) whose
external surface is hair-bearing, while its internal surface defines the
voluminous preputial space housing the mouse penis (Fig. 1A)
(Blaschko et al., 2013; Rodriguez et al., 2011). Also, the mouse has an
internal prepuce that is integral to the distal aspect of the mouse penis
and thus is similar/homologous to the human prepuce (Blaschko et al.,
2013) (Fig. 1A–B). Development of the internal prepuce of the mouse
has not been adequately described.
Morphogenesis of the external prepuce of the mouse occurs via a
developmental mechanism entirely different from that of human pre-
putial development (Cunha et al., 2019c; Liu et al, 2018a, 2018b). See
companion paper, “Development of the human prepuce“ Cunha et al.,
(2019c). The mouse prepuce develops as a result of midline fusion of
the preputial swellings, for which there is no human counterpart.
Moreover, malformations of the mouse external prepuce elicited by
developmental exposure to exogenous estrogens differ substantially
from spontaneous preputial malformations in humans (Cunha et al.,
2019c; Cunha et al., 2015; Mahawong et al., 2014a, b). Development of
the mouse internal prepuce has only been described superficially
(Schlomer et al., 2013; Sinclair et al., 2016a), but the data clearly es-
tablish that the mouse internal prepuce and the human prepuce differ
greatly in anatomy and development even though both are integral to
the glans penis (Cunha et al., 2019c; Liu et al, 2018a, 2018b).
3. Penile morphology and development
The penis develops from the embryonic genital tubercle in all
mammalian species, even though penile morphology is vastly different
in humans, mice and many other species (Simmons and Jones, 2007).
The mouse penis has a substantial fibrocartilaginous projection ex-
tending beyond the urethral meatus (the male urogenital mating pro-
tuberance, MUMP) that is absent in humans (Figs. 1 and Fig. 2D & E)
(Rodriguez et al., 2011; Yang et al., 2010). Also, the mouse penis
contains bone (os penis) and an associated zone of hyaline cartilage,
again structures lacking in humans. Morphogenesis of these anatomic
structures relies on developmental processes expressed in mouse and
not in humans. Thus, use of the mouse penis to model human penile
development requires caution so as to focus on those developmental
features shared in common.
Anatomical nomenclature of the mouse penis also differs sub-
stantially from human and must be understood to avoid confusion. For
all species the penis consists of two parts: (a) an external portion pro-
jecting from the body wall and (b) an internal portion lying beneath the
body surface contour. For humans, the internal portion consists of the
proximal attachments of the corpora cavernosa (crura) to the inferior
ischio-pubic rami (Clemente, 1985). In humans, the external (or
Fig. 1. The mouse penile glans (A) lies within an extensive pre-
putial space defined by the hair-bearing external prepuce, which
forms the prominent elevation in the perineum (C). Comparison of
(A & B) suggests homology between the human prepuce and the
mouse “internal prepuce” (both red) in so far as both are integral to
the distal aspect of the penis and encircle the glans. (C & D) Side
views of male (C) and female (D) mouse perineal appendages (la-
beled external genitalia). The MUMP (male urogenital mating
protuberance) is a fibrocartilaginous process that extends ~1mm
beyond the urethral meatus in mice (A). (For interpretation of the
references to colour in this figure legend, the reader is referred to
the Web version of this article.)
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pendulous) portion consists of the shaft or body of the penis containing
the corporal body (fused corpora cavernosa) and the corpus spon-
giosum surrounding the urethra (Fig. 2). The distal aspect of the corpus
spongiosum forms the glans and contains the urethral meatus
(Clemente, 1985). For the mouse, the internal portion of the penis
contains the proximal attachments of corpora cavernosa, and the cor-
poral body (fused corpora cavernosa). These internal elements of the
mouse penis lie deep to the preputial space and constitute in part the so-
called the body of the mouse penis. Thus, the term body of the penis
refers in the human to the external pendulous portion, while in the
mouse the body of the penis lies internally (Fig. 2). In mice, a right
angle bend (Fig. 2C) corresponds to the junction between the internal
element, body of the penis, and the external element, the glans, residing
within the preputial space (Fig. 2C–E). The mouse glans contains the os
penis proximally, the fibrocartilaginous MUMP distally, as well as the 5
erectile bodies: (a) the corpus cavernosum glandis, (b) the bilateral
Fig. 2. Adult human and mouse penile anatomy. (A)
Drawing of human penis in mid-sagittal view and (B) in
transverse section. Note junction of the pendulous ex-
ternal portion and the internal portion of the human penis
indicated by the dotted line in (A). (C) Photograph of a
dissected adult mouse penis. The junction between the
internal and external portions of the mouse penis occurs
at the right-angle bend denoted by the dotted line and
associated labels, “internal” and “external”. The forceps
hold one of the bilateral crura. The internal portion con-
tains the body of the mouse penis, while the external
portion is called the glans. The glans in (C) cannot be seen
because it lies within the preputial space (dotted lines);
the position of the glans is indicated by . (D)
Mid-sagittal hematoxylin–eosin stained section of the
adult mouse penis with the external prepuce removed. (E)
The mouse glans penis within the proximal portion of the
external prepuce. Note reflection of epithelium of the
external prepuce onto the surface of the penis indicated
by the large solid arrows in both (D & E). (Adapted from
Rodriguez et al., 2011 and Cunha et al., 2015 with per-
mission).
G.R. Cunha, et al. Differentiation 110 (2019) 49–63
51
MUMP corpora cavernosa, and (c) the bilateral corpora cavernosa ur-
ethrae (Sinclair et al., 2016b; Weiss et al., 2012). The body of the mouse
penis contains the corporal body, and thus the mouse has 6 erectile
bodies in total. Humans have only two penile erectile bodies, namely
the corporal body and the corpus spongiosum (Fig. 2A–B) (Clemente,
1985). The corpus spongiosum in humans entirely surrounds the ure-
thra (Fig. 2B). Its counterpart in mice, the corpora cavernosa urethrae,
does not surround the urethra, but instead lies ventral to it (Sinclair
et al., 2016b). Little is known about development of the mouse penile
erectile bodies, except that they form from mesenchymal cell con-
densates (Blaschko et al., 2013; Rodriguez et al., 2012). As is all too
easily appreciated, differences in the terminology and anatomy of the
mouse and human penis can be a source of confusion.
In mice the formation of penile erectile bodies is androgen-depen-
dent. This interpretation rests upon the following observations: (a) Male
mice develop 6 penile erectile bodies, while female mice are devoid of
erectile bodies in their external genitalia (clitoris) (Weiss et al., 2012);
(b) Androgen insensitive male XTfm/Y mice have completely feminized
external genitalia, which includes a clitoris devoid of erectile bodies
(Weiss et al., 2012); and (c) Mesenchymal condensates, the precursors
of penile erectile bodies, are composed of androgen receptor-positive
mesenchymal cells (Blaschko et al., 2013; Rodriguez et al., 2012).
Clearly, formation of mouse penile erectile bodies depends upon an-
drogen. This mechanistic scenario (androgenic induction of erectile
body development) in mice does not apply to humans, in which cor-
poral bodies are present in both the adult and fetal human penis and
clitoris (Clemente, 1985; Cunha et al., 2019b). Moreover, corporal
bodies form in both sexes as early as 8–9 weeks of development (and
probably earlier) when testicular androgen production is either nil or
just starting. Thus, embryonic formation of erectile bodies is surely
androgen-independent in humans, whereas erectile body formation is
androgen-dependent in mice (Cunha et al., 2019b).
Mouse and human penises develop from the genital tubercle, a
projection in the embryonic perineum. In both species and both sexes
the genital tubercle contains a solid urethral plate that extends to near
the distal tip of the genital tubercle (Baskin et al., 2018; Hynes and
Fraher, 2004a; Li et al., 2015; Overland et al., 2016; Seifert et al.,
2008). Despite these features common to both human and mouse,
considerable anatomical differences are seen in penises of these two
species, thus profound developmental variances are expected. This is
especially true for penile urethral development.
For both mouse and human, two entirely different morphogenetic
mechanisms are in play for penile urethral development: (a) epithelial
fusion events and (b) direct canalization of the solid urethral plate. In
mice, the proximal portion of the penile urethra forms via direct ca-
nalization of the urethral plate (Fig. 3A) (Hynes and Fraher, 2004b;
Seifert et al., 2008). In contrast, the distal portion of the mouse urethra,
and especially the urethral meatus, forms via requisite epithelial fusion
events (Liu et al., 2018a). Conversely, in humans (Fig. 3B) formation of
the urethra within the glans occurs via direct canalization of the ure-
thral plate, whereas proximally within the human penile shaft, the
urethra forms via fusion of the urethral folds (Baskin et al., 2018; Li
et al., 2015). Thus, both mechanisms of penile urethral formation occur
in mice and humans, but the location of developmental mechanisms is
exactly opposite in these species. Of note, hypospadias in humans oc-
curs most frequently at precisely the junction of these two disparate
morphogenetic mechanisms, namely at the glans/shaft interface
(Baskin and Ebbers, 2006; Baskin et al., 1998; Cunha et al., 2015; Liu
et al, 2018a, 2018b).
4. Hypospadias
Hypospadias is a common congenital malformation in humans.
Indeed, it is the second most common congenital anomaly in boys,
occurring in approximately 1:200–1:300 male births (Baskin, 2000).
Hypospadias consists of the following spectrum of anomalies: (a)
abnormal positioning of the urethral meatus, (b) absence of the ventral
prepuce, (c) thinning or absent corpus spongiosum and (d) chordee
(abnormal penile curvature) (Baskin et al., 1998). About 50% of pa-
tients with hypospadias have defects occurring at the glans–shaft
junction or distally in the glans (Baskin and Ebbers, 2006). Spontaneous
hypospadias has never been reported in wild-type mice. Moreover, the
anatomic patterns of hypospadias in mice (and rats) experimentally
induced by exogenous estrogenic differ substantially from that seen in
humans both in position and morphology. This is not surprising given
the substantial differences in morphology of the human versus the
mouse penis. For example, one form of mouse hypospadias induced by
exogenous estrogen is defined by whether the os penis is present in the
same transverse section with the ventral cleft in the MUMP ridge
(Mahawong et al., 2014b). While this may be a valid form of mouse
hypospadias, it bears little resemblance to human hypospadias. Like-
wise, estrogen-induced malformation of the mouse penile urethral
meatus (Mahawong et al., 2014a, b; Sinclair et al., 2016a; Sinclair et al.,
2016b) is completely different from human hypospadias, which is il-
lustrated in an accompanying paper (Cunha et al., 2019c). These dif-
ferences led us to question the use of estrogen-induced mouse penile
malformations as a model for human hypospadias (Cunha et al, 2015,
2019c; Sinclair et al., 2016b). Flutamide-induced rat and mouse hy-
pospadias appears to be a better model for hypospadias (Sinclair et al.,
2017; Zheng et al., 2015).
5. Clitoral morphology and development
Mouse and human clitori are entirely different anatomically, and
the vast anatomic differences are accounted for by corresponding dif-
ferences in developmental processes (Baskin et al., 2018; Cunha et al.,
2019a; Overland et al., 2016). The human clitoris is a diminutive ver-
sion of the human penis, except for the absence of the urethra
(Clemente, 1985). Like the penis, the human clitoris has a shaft, glans
and a corporal body. The human clitoris develops from the embryonic
genital tubercle, and like the human penis projects externally from the
body surface, albeit minimally (into the vaginal vestibule) (Clemente,
1985). Development of the human clitoris is remarkably similar to that
of the human penis (Baskin et al., 2018; Li et al., 2015; Overland et al.,
2016) with the exception that the urethra does not form within the
human clitoris. An early event in development of both the penis and
clitoris is the canalization of the urethral/vestibular plate to form a
wide urethral/vestibular groove (Baskin et al., 2018; Li et al., 2015;
Overland et al., 2016). In males the edges of the groove (urethral folds)
fuse to form the penile urethra (Li et al., 2015). In contrast, in human
females the edges of the vestibular groove (vestibular folds) remain
separate as the labia minora that define the vaginal vestibule (Baskin
et al., 2018; Overland et al., 2016).
Unlike the human clitoris, the mouse clitoris is entirely devoid of
erectile bodies and is defined by an internally located U-shaped epi-
thelial lamina (the clitoral lamina) (Martin-Alguacil et al., 2008a; Weiss
et al., 2012), whose development is tangentially related to the genital
tubercle (Cunha et al., 2019a). First and foremost, it must be recognized
that the prominent appendage seen in the perineum of an adult female
mouse in not the clitoris, but instead is female prepuce (Sinclair et al.,
2016c) that forms from the preputial swellings that are not present in
humans (Cunha et al., 2019a). The U-shaped clitoral lamina forms via
fusion of the preputial swellings with the epidermis of the genital tu-
bercle to form the circumferential preputial lamina, which remodels
into the U-shaped clitoral lamina (Cunha et al., 2019a). See the ac-
companying paper on mouse clitoral development that emphasizes the
many differences in mouse/human clitoral anatomy and development
(Cunha et al., 2019a).
6. Prostate
Prostatic development in mice and men is similar in many aspects
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and substantially different in others. The principal common feature is
that prostatic development is androgen-dependent in both species.
Many common mouse/human features of prostatic development have
been reported previously (Cunha et al, 1987, 2018c; Keil and Vezina,
2015; Timms, 2008; Vezina and Bushman, 2007). Human/mouse pro-
static differences include the following:
A. Prostatic anatomy: The prostate of humans and rodents have si-
milar anatomical and functional roles, however there are also sig-
nificant differences that distinguish prostates of these species.
Knowledge of the anatomy and histology and their ultimate roles in
physiology are key to the interpretation of modeling the murine pros-
tate for human benign prostatic hyperplasia.
The mouse prostate consists of four paired lobes: the anterior,
ventral, dorsal, and lateral lobes. Due to the close proximity of the
dorsal and lateral lobes, they are commonly referred to as the dorso-
lateral lobe. Contrasting the lobes of the rodent, the human prostate is
categorized by zones (e.g. central, transition and peripheral) and are
encompassed together by a thick fibromuscular capsule. The corre-
sponding prostatic lobes of the mouse for human central, transition and
peripheral zones remain a matter of continued debate. The lobes of the
rodent prostate are individually enclosed in thin delicate capsules and
thus loosely surround the prostatic urethra. The rodent prostatic lobes
are elongated, opaque, and tube-like in appearance and are described
based on their anatomical location around the rhabdosphincter (i.e.
dorsally, laterally, ventrally, and anteriorly) near the base of the
bladder.
A further anatomical difference between the rodent and human is
the location of the anterior prostate, also known as the coagulating
gland, which in mice is immediately adjacent to the seminal vesicle and
located cranially to the other prostate lobes. The intimate association of
Fig. 3. Diagrams of divergent development of mouse (A) and human (B) penile urethral development. (A) The proximal portion of the mouse penile urethra (within
the glans) develops via direct canalization of the urethral plate, while the distal aspect of the mouse penile urethra and the urethral meatus forms via epithelial fusion.
(B) The distal portion of the human penile urethra (within the glans) develops via direct canalization of the urethral plate, while the proximal portion of the human
penile urethra within the shaft forms via fusion of the urethral folds.
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the mouse anterior prostate with the seminal vesicle does not have a
human counterpart. The mouse prostatic lobes project into the ab-
dominal cavity and the ducts convey prostatic fluids during ejaculation
into the urethra (Nicholson et al., 2012).
Mouse and human prostates develop from solid epithelial buds
emerging from endodermal urogenital sinus epithelium (UGE) (Cunha
et al, 1987, 2018c). Such buds emerge at specific anatomic points in
both species to give rise to specific prostatic lobes in mice (Sugimura
et al, 1986a, 1986b) and to a specific prostatic zonal anatomy in hu-
mans (Lowsley, 1912; McNeal, 1981, 1983). Epithelial buds emerge
from the ventral UGS in both species. In mice (and rats) this leads to the
formation of the ventral prostatic lobe (Hayashi et al., 1991; Sugimura
et al., 1986a). In humans the ventral prostatic buds (Cunha et al.,
2018c; Lowsley, 1912) regress during fetal life, and thus a “ventral lobe
equivalent” is not to be found in the adult human.
B. Intra-prostatic ejaculatory ducts and prostatic utricle: In humans,
the seminal vesicle duct joins the vas deferens bilaterally to form the
paired ejaculatory ducts that traverse the prostate to open into the
prostatic urethra on the apex of the verumontanum lateral to the pro-
static utricle (Cunha et al., 2018c). In mice, ejaculatory ducts, formed
by fusion of seminal vesicle ducts with the vas deferens, have been
described in some reports (Lin et al., 2003; Timms and Hofkamp, 2011),
while in others, the vas deferens and bilateral seminal vesicle ducts
open separately into the prostatic urethra (Cunha et al., 2018c; Green,
1966). Therefore, while some degree of homology exists in the ver-
umontanum and its associated “ducts” between mouse and human,
distinct anatomical differences exist and imply differences in develop-
mental processes.
C. Prostatic squamous metaplasia and the complications of alpha-
fetoprotein in the neonatal mouse: The developing human prostate is
susceptible to effects of the high levels of maternal estrogens in the
third trimester (Boroditsky et al., 1978; Dawson et al., 1983). Prostatic
squamous metaplasia is a striking and consistent manifestation of ma-
ternal estrogens in the third trimester (Zondek and Zondek, 1979). In
contrast, spontaneous prostatic squamous metaplasia has never been
reported in mice, even though prostatic squamous metaplasia can be
induced in mice by exogenous estrogens such as estradiol or diethyl-
stilbestrol (DES) (Risbridger et al., 2001). The absence of spontaneous
prostatic squamous metaplasia in mice can be attributed to high levels
of alpha-fetoprotein (AFP) produced prenatally and neonatally by the
mouse (and rat) liver. AFP in these species binds estrogen at high af-
finity (Uriel et al., 1976), and the levels of AFP in rat (and mouse)
serum are particularly high. Thus, endogenous serum estrogen of either
fetal or maternal origin is sequestered in mice and is not available for
entry into target cells. In contrast, human AFP does not bind estrogens
(Swartz and Soloff, 1974), and thus in humans, endogenous and exo-
genous estrogens are free to interact with target cells and to elicit
prostatic squamous metaplasia (and in females stimulate breast, uterus
and vagina) during the perinatal period (Driscoll and Taylor, 1980;
Yonemura et al., 1995; Zondek and Zondek, 1979). After birth prostatic
squamous metaplasia disappears.
The presence AFP in neonatal mice has profound effects on estrogen
action on all estrogen target organs and this fact must be taken into
consideration in experimental design and interpretation of results. An
example of problems that can arise in the use of neonatal mice is illu-
strated in a recent paper by Zheng et al. This elegant paper provides
some interesting and important ideas concerning hormone-induced
malformations of the external genitalia of mice elicited by disrupting
AR signaling via genetic or anti-androgen treatment as well as via
treatment of newborn mice with a pharmacological dose of estradiol
benzoate (Zheng et al., 2015). Effects of the massive dose of estradiol
benzoate included profound down-regulation of androgen receptor
(AR) within the developing penis, widespread induction of ERα ex-
pression in female external genitalia, and effects on proliferation,
apoptosis and gene expression in male and female external genitalia
(Zheng et al., 2015). With respect to Esr1 (ERα) signaling, the authors
explicitly discuss the relevance of their pharmacologic estrogen studies
in relation to normal development of male and female external geni-
talia. Simply put, it is not possible to interpret outcomes as normal
when effects are elicited by a pharmacological dose of estradiol. Such
an interpretation is unjustified and certainly inconclusive for many
reasons: (a) It is sobering to note that a dose of estradiol at 1 μg/kg is
sufficient to elicit a strong stimulation of uterine epithelial proliferation
in adult mice (AFP is absent) (Nanjappa et al., 2019). The dose used in
the Zheng et al. paper on neonates was 300 μg/kg, that is, 300 times
that required to elicit adult uterine epithelial growth. The reason for the
pharmacologic dose used by Zheng et al. is the well-known fact that in
order to elicit estrogenic effects in neonatal mice, pharmacologic doses
are required to overcome the “neutralizing” effect of AFP. It is un-
acceptable and inappropriate to apply the term “normal” to an ex-
periment in which a pharmacologic estrogen dose was administered at
least 300 times above physiologic. In addition, the author's explicit
statement that estradiol/ERα signaling is occurring in “normal” (un-
treated) neonatal female mice can be challenged on several grounds: (1)
Several effects of estrogens have been previously reported in neonatal
female mice treated with pharmacologic doses of estrogen (Bern et al.,
1984; Bern and Talamantes, 1981; Forsberg and Kalland, 1981;
McLachlan et al., 1980). None of these classic estrogenic responses have
been reported in untreated or oil-treated wild-type female neonatal
mice, perhaps for two reasons: (a) estrogen levels are extremely low in
neonatal rodents (Pang et al., 1979) and (b) low levels of estrogen in
neonatal mice are likely to be sequestered by AFP as discussed above.
(2) The body of evidence in the literature support the idea that estro-
genic responses may not even occur in untreated wild-type female
neonatal mice during the period when AFP is present (birth to ~20 days
postnatal). This idea is supported by several observations: (a) Esr1KO,
Esr2KO, or Esr1/Esr2KO male mice exhibit normal internal and ex-
ternal genital structures that are indistinguishable from their wild-type
littermates (Couse and Korach, 1999a, b; Nef and Parada, 2000). (b)
Proliferation of uterine luminal epithelial cells, uterine stromal cells,
and glandular epithelium is comparable in untreated wild-type, het-
erozygotes, and Esr1KO mice examined sequentially from day 2–22
postnatal. Adenogenesis, the formation of uterine glands, is also com-
parable in these 3 groups (Nanjappa et al., 2015). The fact that values
for all of these parameters were virtually identical in untreated wild-
type and Esr1KO mice suggest that Esr1 signaling is not involved in
uterine growth (and perhaps globally in other organs) from birth to at
least 22 days postpartum. Moreover, estrogen deprivation via neonatal
ovariectomy alone or neonatal ovariectomy plus adrenalectomy causes
no significant reduction in neonatal uterine growth relative to control
(Ogasawara et al., 1983). Thus, disruption of estrogen receptor genes as
well as ablation of estrogens via ovariectomy and adrenalectomy is
inconsistent with estrogenic signaling in normal untreated neonatal
mice. Moreover, studies using pharmacologic doses of estradiol
benzoate cannot be considered to reflect normal physiology/develop-
ment of estrogen target organs. Finally, knowledge of mouse anatomy is
critical. The structure designated as mouse clitoris and illustrated as
such (Zheng et al., 2015), is not clitoris, and instead is prepuce (Cunha
et al., 2019a; Mahawong et al., 2014b; Martin-Alguacil et al., 2008b;
Sinclair et al., 2016c; Weiss et al., 2012; Yang et al., 2010).
Another important mouse/human difference concerns the response
to the so-called “anti-estrogen”, tamoxifen. While tamoxifen is used
therapeutically as an anti-estrogen in humans (Marth et al., 1984;
Moseson et al., 1978), tamoxifen is an estrogen in mice (Diwan et al.,
1997; Takamatsu et al., 1992). Thus, the use of tamoxifen-inducible
gene constructs at a pharmacologic tamoxifen dose of (80mg/kg)
(Zheng et al., 2015) is potentially a serious complication for prenatal
targeting of transgenes to reproductive tract organs. The mechanisms
involved in whether tamoxifen acts as an anti-estrogen or an estrogen in
either species is complex and depends on dose, target tissue, timing of
exposure and molecular regulators present in a particular tissue. Cau-
tion is urged.
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D. Prostatic basal cells: The function of prostatic basal cells has been
and continues to be a source of interest. Prostatic basal cells lie on the
epithelial basement membrane and express a spectrum of differentia-
tion markers distinguishing them from the secretory luminal cells
(Table 1). In humans, prostatic basal epithelial cells form a continuous
uninterrupted layer beneath the luminal cells (Andrews, 1951;
Bonkhoff et al., 1994; Srigley et al., 1990), whereas in mice the basal
cell layer is discontinuous (Hayward et al., 1996a). The significance of
this difference is unclear. Insight into the function of prostatic basal
cells is derived from a study by Takeshi Kurita and colleagues who
created mature mouse prostate that lacked basal cells (Kurita et al.,
2004a), an achievement produced by “rescuing” prostates from p63-
deficient mice by grafting into adult male hosts. This approach was
required as p63-deficient mice die at birth, which is well before the
prostate has differentiated. p63 is a protein normally expressed in
prostatic basal cells, and such p63-knockout prostates are devoid of
basal cells. Anomalies found in these basal-cell-deficient prostates in-
clude: (a) Abnormal PAS-reactive mucinous goblet cells within the
prostatic epithelium; (b) A profoundly exaggerated response to an-
drogen deprivation; (c) Impaired prostatic regeneration from the an-
drogen-deficient state following treatment with exogenous testosterone
(Kurita et al., 2004a). The higher proportion of basal epithelial cells in
human versus mouse prostates may have important consequences. The
role of prostatic basal epithelial cells in carcinogenesis remains to be
defined as data on this subject is conflicted. Loss of prostatic basal cells
occurs early in the carcinogenic process in humans and rats (Bostwick,
1996; Wong and Tam, 2002), yet prostatic basal epithelial cells are said
to regulate and suppress human prostate cancer cells (Miniati et al.,
1996).
E. Prostatic stroma: During the fetal period the prostatic connective
tissue of both mice and humans is undifferentiated and appropriately
designated as urogenital sinus mesenchyme (UGM), which induces and
specifies prostatic epithelial differentiation (Cunha et al., 1987). In the
course of development, the UGM differentiates into smooth muscle, a
process that requires a signal(s) from the developing prostatic epithe-
lium (Cunha et al., 1992). In mice and rats, thin smooth muscle bundles
form immediately around the prostatic ducts (Cunha et al, 1992, 1996).
Accordingly, adult mouse (and rat) prostatic stroma contains only a
small proportion of smooth muscle cells, as the connective tissue be-
tween prostatic ducts is devoid of smooth muscle.
In contrast, adult human prostatic stroma contains vastly more
smooth muscle. Indeed, adult human prostatic stroma is predominantly
smooth muscle (Cunha et al., 1996; Hayward et al, 1996b, 1997). The
significance of this mouse/human difference is not known, but as pro-
static carcinogenesis is initiated in humans, a “reactive stroma” de-
velops in which the smooth muscle cells lose differentiation markers
and transform into myofibroblastic cells (Ayala et al., 2003; Tuxhorn
et al., 2002). Dedifferentiation of smooth muscle cells also occurs in rat
prostatic carcinogenesis (Wong and Tam, 2002). The resultant human
carcinoma-associated fibroblasts promote tumorigenesis (Olumi et al.,
1998). Moreover, the nature and extent of stromal changes occurring
during human prostatic carcinogenesis have predictive/prognostic im-
plications (Ayala et al., 2003; Tuxhorn et al., 2002; Yanagisawa et al.,
2007). Finally, evidence suggests that the smooth muscle layer reg-
ulates signaling between prostatic mesenchyme and epithelium during
prostatic development in rats, and thus comprises part of the me-
chanism regulating prostatic induction (Thomson et al., 2002). For
these reasons, the status of smooth muscle in developing and adult
rodent versus human prostates deserves further research.
F. Prostatic ductal branching morphogenesis. Rat and mouse pro-
static buds emerge from the UGE and grow peripherally toward me-
senchymal densities called mesenchymal pads in which ductal
branching initiates (Thomson and Cunha, 1999). The ventral me-
senchymal pad is the most extensively studied (Thomson and Cunha,
1999; Timms et al., 1995), even though there are also dorsal-lateral
mesenchymal pads in which the dorsal-lateral prostate develops. The
ventral mesenchymal pad is rich in FGF7 and FGF10 (Finch et al., 1995;
Thomson and Cunha, 1999). Once the elongating prostatic buds enter
the ventral mesenchymal pad, profuse ductal branching occurs. Up to
and throughout the period of ductal branching, the mesenchymal pads
are devoid of smooth muscle markers (Thomson et al., 2002). This is
not the case for human prostatic development as ductal branching oc-
curs within fields of undifferentiated prostatic mesenchyme as well as
in fields of smooth muscle (Fig. 4) (Cunha et al., 2018c).
G. Prostate cancer: Prostate cancer is one of the most common
neoplasms affecting men, occurring in up to 80% of men who reach the
age of 80 years (Crawford et al., 2001). In contrast, spontaneous
prostate cancer is extremely rare in mice and rats. The reasons for this
vast difference remain unknown, however exposure to developmental
events such as high levels of estrogens may play a role.
Table 1
Protein differentiation markers of prostatic basal and luminal epithelial cells.
Differentiation marker Basal cells Luminal cells Reference
p63 Yes No Weinstein et al. (2002)
Keratin 14 Yes No Weinstein et al. (2002)
Keratin 5/6 Yes No Abrahams et al. (2002)
Keratin 7 No Yes Trompetter et al. (2008)
Keratin 8 No Yes Hudson et al. (2001)
Keratin 17 Yes No Trompetter et al. (2008)
Keratin 18 No Yes Hudson et al. (2001)
Keratin 19 No Yes Peehl et al. (1996)
Keratin 20 No Yes Trompetter et al. (2008)
Androgen receptor Noa Yes Cunha et al. (1987)
a Most studies indicated that prostatic basal cells are AR-negative.
Fig. 4. Human fetal prostates at 15 (A) and
19 weeks (B) stained for smooth muscle
actin. At 15 weeks (A) smooth muscle has
differentiated ventrally and is just beginning
to appear dorsally. By 19 weeks (B) smooth
muscle has differentiated circumferentially
around the developing prostate. Ductal
branching has occurred in the smooth-
muscle-poor central region as well as in the
peripheral smooth-muscle-rich region.
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H. Benign prostatic hyperplasia (BPH): BPH afflicts a large propor-
tion of aging men and may lead to urethral obstruction (McNeal, 1985).
A key comparative difference between mouse and human prostates is a
thick fibromuscular capsule that surrounds the human prostate; mice
and rats have no such entity surrounding the prostatic lobes to collec-
tively unify the entire organ. The thick collagenous capsule in humans
may be an important contributor in the development of urethral ob-
struction associated with BPH. The human prostatic capsule has tradi-
tionally been described to confine growth, especially nodular growth,
thereby creating pressure or impingement on the urethra as it traverses
through the prostate, altering urinary flow and ultimately leading to
urinary symptoms.
The prevalence of BPH increases with age (Gupta et al., 2006;
Prakash et al., 2002). Lower urinary tract symptoms (LUTS) are com-
monly associated with BPH (Girman et al., 1995; Roehrborn et al.,
1999). BPH is postulated to lead to symptoms due to development of a
bladder outlet obstruction. This is because the urethra passes through
the human prostate gland, and proliferation of tissues within the
prostate are confined by the prostatic capsule which serves to restrict
outward expansion of prostatic tissues. Instead, enlarging prostatic
nodules push inward on the urethra potentially causing urinary ob-
struction. In this context, expansion of hyperplastic prostatic tissues can
impede urinary flow, leading to obstructive symptoms. As such, trans-
urethral resection of the prostate (TURP) is used to remove impinging
tissue and allow for an “open” channel within the prostate.
Other than humans, dogs are the only other species to sponta-
neously develop BPH. Recently, aged mice were found to have cellular,
anatomical, and functional aspects of BPH (Liu et al., 2019). For dec-
ades, it was believed that mice would not make good models for BPH/
LUTD research because the anatomy of distinct prostatic lobes in mice
is anatomically dissimilar to that of the human prostate. To this point,
mouse prostatic lobes surround the rhabdosphincter/urethra, but are
not encompassed by thick connective tissue capsule as found in men.
Although these anatomical differences have been cited previously as
grounds for not using mice in urinary dysfunction research, a careful
examination of the prostatic ducts entering into the mouse urethra
suggests that the adult mouse prostatic urethra shares in parallel fea-
tures with the human transition zone in that it directly surrounds the
urethra. Although the mouse urethra is not encompassed by a thick
tunica of collagen, it is surrounded by a dense muscular stroma known
as the rhabdosphincter, which forms a “border” analogous to the cap-
sule of the human prostate. Indeed, an increase in periurethral prostatic
ductal growth is associated with lower urinary tract dysfunction in both
mice and men. As such, a similar anatomical/cellular impingement
“mechanism” exists in both men and rodents. Moreover, this obstruc-
tion is associated with mouse urinary dysfunction (Liu et al., 2019;
Nicholson et al, 2012, 2015; Ricke et al., 2018). Thus, rodents have
been successfully used to model BPH in humans.
Alternatives to prostate hyperplasia as the driving force in BPH/
bladder outlet obstruction and subsequent urinary symptoms is devel-
opment of smooth muscle tone and prostatic urethral fibrosis. Mouse
models of prostatic smooth muscle contractility are limited, and it is
uncertain if there are physiological consequences in the mouse that lead
to LUTD. Nonetheless the mouse prostatic urethra does contain smooth
muscle and hence may serve as a model for hypercontractility in LUTD
(Liu et al., 2019).
Prostatic fibrosis results in a lack of urethral compliance, and hence
may lead to bladder outlet obstruction, an idea currently being assessed
in mouse models. Normally, as urine passes through the prostatic ure-
thra, the urethra stretches and expands to achieve maximal urinary
flow. If the urethra cannot expand or is smaller in diameter due to fi-
brosis of the surrounding periurethral tissue, this may explain why
some men are not responsive to medical therapies for BPH, which do
not target fibrosis. Additionally, it may explain why men with small
non-hyperplastic prostates have BPH/LUTS. These processes as well as
other experimental concepts are perhaps the most relevant reasons for
using rodents as models for BPH/LUTS.
7. Female reproductive tract development
A. Müllerian duct development: In females the bilateral Müllerian
ducts give rise to the oviducts/uterine tubes, uterus, cervix and the
vagina (Kurita and Nakamura, 2008; Robboy et al., 2017). In both
humans and mice the bilateral Müllerian ducts fuse in the midline, but
the degree of fusion differs vastly in these two species (Robboy et al.,
2017). In mice, only the caudal-most portions of the Müllerian ducts
fuse to form a relatively short cervical canal and the so-called Müllerian
vagina, which in the neonate forms the upper portion of the vagina and
includes the vaginal fornices (Kurita, 2011) (Fig. 5). Most of the Mül-
lerian ducts in mice remains separate (unfused) and forms the bilateral
uterine horns and oviducts (Kurita, 2011; Kurita and Nakamura, 2008;
Robboy et al., 2017) (Fig. 6). In contrast, in humans all but the cranial
portions of the Müllerian ducts fuse to form the uterovaginal canal, the
primordium of the uterine body, cervix and vagina (Cunha et al.,
2018b; Robboy et al., 2017). The unfused cranial portions of the human
Müllerian ducts form the uterine tubes, also known as the Fallopian
tubes (Fig. 6). Thus, from a morphogenetic perspective Müllerian duct
development differs considerably in mice and humans (Fig. 6).
During female reproductive tract development the Müllerian ducts
grow caudally in both mice and humans to fuse with the epithelium of
the urogenital sinus (UGS) (Koff, 1933; Kurita, 2010; O'Rahilly, 1973).
In humans, the Müllerian duct/UGS junction fluctuates with time. In-
itially in humans the Müllerian duct/UGS junction is near the bladder in
females (Koff, 1933), but by 12 weeks this junction descends caudally
to near the vaginal introitus (Koff, 1933; Robboy et al., 2017). In mice,
the Müllerian duct/UGS junction becomes situated cranially in males
and more caudally in females, even though the initial point of contact of
the Müllerian ducts with the UGS is high (near the bladder) in both
sexes. The subsequent male/female positional difference in mice is at-
tributed to the timing and the duration of androgen action during fetal
Fig. 5. Diagram of the reproductive tract of a neonatal mouse. The fused
Müllerian ducts form the cervical canal (Cx) and the Müllerian vagina (M. vag.).
The unfused Müllerian ducts form the uterine horns and oviducts. The
Müllerian vagina contacts the solid sinus vagina whose epithelium is derived
from the urogenital sinus.
G.R. Cunha, et al. Differentiation 110 (2019) 49–63
56
stages (Larkins et al., 2016). The absence of androgen action in females
accounts for a more caudal positioning of the Müllerian duct/UGS
junction in mice, while androgen action in males accounts for the more
cranial positioning of the Müllerian duct/UGS junction. In humans (as
in mice) the positioning of the Müllerian duct/UGS junction is cranial in
males (Cunha et al., 2018c) and caudal in females (Cunha et al., 2018b;
Robboy et al., 2017). The mechanism of this sexually dimorphic posi-
tioning of the Müllerian duct/UGS junction in humans has not been
explored adequately. However, the proposed role of androgens (based
upon mouse studies) in positioning the Müllerian duct/UGS junction in
males and females (Larkins et al., 2016) is doubtful in humans for
several reasons: (a) The initial cranial position of the human Müllerian
duct/UGS junction described previously (Cunha et al., 2018c; Koff,
1933) in males is established at about 8 weeks of gestation when an-
drogen levels are low or non-existent. (b) The fetal testes begin tes-
tosterone production at about 8–10 weeks of gestation (Siiteri and
Wilson, 1974). (c) The first concrete evidence of androgen action in
human males is initiation of prostatic bud formation which occurs at 10
weeks. Thus, it is unlikely that androgens play a role in the cranial
positioning of the Mullerian duct/UGS junction in human males. In
human female fetuses, the Müllerian duct/UGS junction is established
at ~8 weeks shortly below the bladder as in males, but over the next
3–4 weeks the Müllerian duct/UGS junction translocates caudally to the
region of the vaginal introitus (Cunha et al., 2018b; Koff, 1933; Robboy
et al., 2017). The mechanism of this positional change is not known.
Whether in humans these male/female differences in the insertion of
the fused Müllerian ducts (uterovaginal canal) with the UGS are attri-
butable to androgen action in males or the lack of androgen action in
females is uncertain as the spatial distribution of androgen receptors
remains unresolved in developing human male and female reproductive
tracts at the required ages.
B. Derivation of vaginal epithelium: The question of vaginal epi-
thelial derivation was debated for decades both for humans (Cunha
et al., 2018b; O'Rahilly, 1977; Robboy et al., 2017) and mice (Kurita,
2010). Initially, speculation on the derivation of human and mouse
vaginal epithelium was based mostly upon histologic analysis (Bulmer,
1957; Forsberg, 1973; Koff, 1933). To reveal the derivation of vaginal
epithelium in mice, Kurita utilized transgenic mice in which an en-
hanced green fluorescent protein (EGFP) reporter irreversibly labeled
the Müllerian, Wolffian or UGS epithelia (Kurita, 2010). Kurita showed
that the vaginal rudiment in mouse embryos and newborns consisted of
the fused Müllerian ducts (Müllerian vagina) plus UGS epithelium
(sinus vagina) (See Fig. 5), which in the transgenic mice were sepa-
rately and irreversibly labeled red and green, respectively. However,
postnatally in mice the proportion of the UGS vaginal epithelium was
progressively reduced as the Müllerian epithelium grew caudally such
that at puberty when the vagina opened, urogenital sinus epithelium
was detected only in the vulva, and not in the vagina. Thus, in mice
adult vaginal epithelium derives solely from Müllerian duct epithelium
(MDE) (Kurita, 2010).
In humans, based upon histologic analysis, Koff (1933) asserted that
vaginal epithelium is mostly derived from Müllerian epithelium with a
minor contribution ascribed to UGE, while Bulmer (1957) concluded
the opposite, namely that virtually all of the human vaginal epithelial
lining derived from UGS. Reich and Fritsch (2014) asserted that the
squamous epithelia of the exocervix and upper vagina are of Müllerian
origin, thus supporting Koff's interpretation. Unfortunately, these pre-
vious studies lacked markers indicative of both Müllerian and ur-
ogenital sinus epithelia. Our recent studies have used PAX2 (a Mül-
lerian epithelial marker) and FOXA1 (an endodermal UGE marker) to
immunohistochemically explore the ontogeny of human vaginal epi-
thelium (Cunha et al., 2018b; Robboy et al., 2017). As in the mouse, the
relative distriburion of PAX2 (a Müllerian epithelial marker) and
FOXA1 (an endodermal UGE marker) changes temporally with devel-
opment. In humans by week 21 when vaginal development is essen-
tially complete, FOXA1-positive UGE was detected from the introitus to
the level of the cervical os, thus supporting Bulmer's interpretation
(Fig. 7) (Cunha et al., 2018b; Robboy et al., 2017). At the external
cervical os the stratified squamous FOXA1-positive epithelium transi-
tions abruptly to a pseudostratified columnar PAX2-positive epithelium
(Cunha et al., 2018b; Robboy et al., 2017). The FOXA1 and PAX2 im-
munostaining was followed sequentially from 12 to 21 weeks with
several specimens spread across this age range, and mirror image
FOXA1/PAX2 immunostaining moved from near the introitus at 12
weeks to the external cervical os at 21 weeks (Robboy et al., 2017).
There are 2 interpretations of this data: (a) FOXA1-positive UGE ex-
tends cranially to replace the Müllerian epithelium up to the external
cervical os. (b) Alternatively, the PAX2-positive Müllerian epithelium
turns off PAX2 expression and turns on FOXA1 expression in a pro-
gressive wave beginning caudally near the introitus and extending
cranially to the external cervical os. This later possibility seems un-
likely. We conclude that the derivation of vaginal epithelium differs
vastly in mice versus humans, surely involving different molecular
mechanisms. Such discoveries emphasize the need to further decipher
how this complicated process proceeds differently in both species.
C. Cervix: Development of the human cervix is poorly understood.
During early fetal life, the future cervix is indistinguishable from the
future uterine corpus or future vagina other than by location. The
human cervix develops within the uterovaginal canal (Fig. 8), a thin
midline epithelial tube formed via midline fusion of the Müllerian
ducts, which is the common primordium of the uterine corpus, cervix
and vagina (Cunha et al., 2018b; Robboy et al., 2017). An un-
differentiated simple columnar epithelium initially lines the embryonic
human uterovaginal canal. In mice only the caudal aspect of the Mül-
lerian ducts fuses to form the cervical canal, exocervix, fornices and the
so-called Müllerian vagina (Fig. 5). Epithelia of all of these structures
will differentiate into a stratified squamous epithelium.
Two epithelial types differentiate in the adult human cervix: (a) A
stratified squamous epithelium lining the caudal (lower) segment of the
cervical canal and covering the surface of the exocervix (that portion of
the cervix projecting into the vaginal vault). These epithelia are similar
to that lining the adult vagina. (b) A simple columnar epithelium lines
the endocervix, whose differentiation is similar to that of epithelium of
the Fallopian tube and uterine corpus. Beginning at about the 16th
gestational week, the Müllerian epithelium lining the endocervix de-
velops simple glandular outpouchings (glands) which later will undergo
mucinous differentiation (Robboy et al., 2017).
Thus, even though the cervix of mice and humans arise in total or in
part from the Müllerian ducts, adult differentiation of cervical epithe-
lium differs significantly in these two species. Mouse cervical epithe-
lium is stratified squamous and non-glandular (identical to that of
Fig. 6. Diagrams of adult human and mouse female reproductive tracts. In
humans most of the Müllerian ducts fuse in the midline and form the uterus,
cervix and contribute to vaginal development, with the unfused cranial portions
forming the uterine tubes. In mice most of the Müllerian ducts remain unfused
to form the oviducts and uterine horns, with the fused portion forming the
cervix and contributing to the vagina.
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vaginal epithelium), whereas human cervical epithelium is stratified
squamous on the exocervix and simple columnar in the endocervix
(Atkins, 2019; Kurita et al., 2001). These two different types of epi-
thelial differentiation in the human cervix may be elicited via region-
specific inductive cues from mesenchyme as has been reported for
murine Müllerian epithelial differentiation (Cunha, 1976; Kurita et al.,
2001). Such mesenchymal-epithelial interactions are known to be at
play in the developing human female reproductive tract (Cunha et al.,
2018a). Alternatively, these differences in epithelial differentiation may
be attributed to differences in germ layer origin, Müllerian for en-
docervix and urogenital sinus for exocervix as discussed above.
D. Mouse oviduct and human uterine tube.
The mouse oviduct and human uterine tube are derived from the
cranial (unfused) portions of the Müllerian ducts. The development of
both of these structures is similar in both species.
E. Progesterone receptor regulation:
Fig. 7. Sagittal sections of a 21-week female reproductive tract. (A) depicts the upper portion of the vagina, cervix and uterus (H&E stain). The vaginal epithelium is
many layers thick due to endogenous estrogenic stimulation. Note the abrupt transition in epithelial differentiation at the vaginal/cervical border. (B) PAX2 staining
of the vaginal/cervical border shows prominent PAX2 immunostaining (indicative of Müllerian duct origin) of the pseudostratified stratified relatively thin cervical
epithelium and PAX2-negative stratified squamous vaginal epithelium. (C) Epithelium of the uterine corpus is strongly PAX2-reactive as expected for a Müllerian
epithelium. (D & E) FOXA1 nuclear immunostaining was seen uniformly throughout the entire vagina, and FOXA1 nuclear immunostaining abruptly stopped at the
vaginal/cervical border (D–E) in mirror image to PAX2 immunostaining (B). (modified from Robboy et al., 2017 with permission). (B & D) are serial sections of the
same specimen.
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Regulation of the progesterone receptor in uterine epithelium differs
substantially in the mouse versus human (Horwitz and McGuire, 1979;
Janne et al., 1975; Kurita et al, 2000, 2005b). In the mouse, uterine
epithelial progesterone receptor (PGR) is strongly expressed following
ovariectomy (that is, in the absence of estrogen) and is profoundly
down regulated upon estrogen administration, an effect mediated in-
directly via stromal estrogen receptor 1 (ESR1) (paracrine mechanism)
(Kurita et al., 2000). In contrast, in humans PGR is up-regulated directly
via ESR1 in uterine epithelium (Cunha et al., 2017; Horwitz and
McGuire, 1979; Janne et al., 1975; Kurita et al., 2005b). Thus, the
progesterone receptor, which has important therapeutic implications in
humans, is regulated in uterine epithelium via opposite mechanisms in
mice versus humans.
F. Vaginal adenosis and vaginal adenocarcinoma:
Vaginal adenosis is a pathological condition in humans and mice in
which glandular tissue is abnormally present in the vagina. The defi-
nition also applies in humans and mice to the presence of a similar
histological type of glandular tissue found in the exocervix (Kurita
et al., 2004b; Robboy et al., 2019). First begun in the early 1940s for
therapeutic purposes, diethylstilbestrol (DES), an inexpensive, synthetic
estrogen, was given to pregnant mothers who were known to have high
risk pregnancies in the belief it would lessen the chance if not prevent
miscarriage. It was not until 1971 that it was recognized that about
1:1000 young women exposed in utero to DES would develop a clear-
cell adenocarcinoma of the vagina or exocervix (Herbst et al., 1974).
The critical period of DES exposure was from about the 8th to 22nd
gestational week, the time when the vagina was undergoing substantial
fetal development. The link to the cancer topographically (Robboy
et al., 1982b) and histologically (Robboy et al., 1984b) was the pre-
sence of adenosis.
Human vaginal adenosis develops in three forms, with the clear cell
adenocarcinoma being linked to only the tuboendometrial form. This
form resembles the Müllerian epithelium typically lining the Fallopian
tube or endometrium: namely cuboidal to columnar glandular epithe-
lial cells having an eosinophilic cytoplasm and a luminal surface that
often is ciliated. The second form, the mucinous columnar epithelial
cell, resembles the typical and normal mucin-rich columnar epithelial
cells lining the normal endocervix; this form has no preneoplastic po-
tential related to estrogen exposure. The third form, the embryonic
form, is occasionally seen in the adult as an isolated gland (Robboy
et al., 1986). This form histologically resembles the embryonic gland-
ular tissue seen in the early fetal female reproductive tract. In the adult,
this form is thought to be a vestigial Müllerian epithelial remnant that
had never transformed into stratified squamous epithelium. When en-
countered, it is always an incidental finding. None of these latter two
forms are known to be linked to prenatal DES exposure.
DES-induced adenosis in mice is linked to the disruption of p63
expression in Müllerian epithelium of the upper vagina, vaginal fornices
and cervical canal. Initially embryonic Mullerian epithelium is simple
columnar and devoid of p63 expression. However, shortly before birth
and in the early neonatal period p63 is expressed in the epithelial cells
of the Müllerian vagina as they transform from simple columnar to
stratified squamous. In the female reproductive tract p63 appears to be
the earliest vaginal epithelial identity marker, which is followed in turn
by other vaginal epithelial markers (Kurita et al., 2005a). Treatment of
neonatal mice with DES beginning at birth focally inhibits p63 ex-
pression in Müllerian vaginal epithelium resulting in the retention of
simple columnar epithelium in the upper vagina, vaginal fornices and
cervical canal. The resultant adenotic epithelium expresses a variety of
protein markers consistent with uterine epithelial differentiation
(Kurita et al., 2004b). While a great deal has been revealed concerning
DES-induce adenosis in mice, DES induction of human vaginal adenosis
is based upon a limited set of specimens.
We have induced adenosis in grafts of human fetal vagina to
athymic mice that were treated with DES (Cunha et al., 2017; Robboy
et al., 1982a). The resultant simple columnar adenotic epithelium ob-
served in vaginae so treated with DES expressed PAX2, a marker of
Müllerian epithelium, and a spectrum of other markers indicative of
simple columnar epithelial cells consistent with a uterine epithelial
phenotype (Cunha et al., 2017). Thus, for both species adenosis appears
to be retained embryonic-like Müllerian epithelium. However, the
mechanistic scenario for DES induction of adenosis has to be considered
in the context of the relative contribution of Müllerian versus urogenital
sinus epithelium to the human vagina, which differs in mice versus
humans as discussed above. In mice, the epithelium of the Müllerian
vagina grows caudally, and at puberty urogenital sinus epithelium has
been completely replaced by Müllerian epithelium (Kurita, 2010). Ac-
cordingly, vaginal epithelium of adult mice is entirely derived from
Müllerian epithelium. Quite the opposite appears to occur in human in
which FOXA1-positive urogenital sinus epithelium initially found in the
most caudal segment of the developing vagina near the introitus ex-
tends cranially apparently replacing the Müllerian epithelium up to the
level of the external cervical os. How this alternate human mechanistic
scenario relates to DES-induced adenosis remains to be determined.
Nonetheless, the DES-induced adenosis expresses PAX2 indicative of its
Müllerian origin.
8. Mammary gland
To fully appreciate the validity and limitations of mouse mammary
development relative to the molecular mechanisms involved in breast
cancer development and progression, it is essential to be aware of the
similarities and differences that exist between the mouse mammary
gland and the human breast (McNally and Stein, 2017). In all mam-
malian species examined the mammary epithelial buds invade from the
basal surface of the embryonic epidermis into the underlying me-
senchyme (Cunha and Hom, 1996; Veltmaat et al., 2003). In mouse
embryos, the epithelial buds invade into an androgen-receptor-rich
mesenchyme, and in male embryos endogenous androgens of testicular
origin elicit regression of the mammary epithelial rudiments
(Kratochwil and Schwartz, 1976). In female mouse embryos due to the
absence of androgens, the mammary buds are retained and subse-
quently form a branched ductal network (Cowin and Wysolmerski,
2010; Richert et al., 2000) which postnatally become lactogenic when
hormonally stimulated (Nandi, 1958). In the human male, the
Fig. 8. Light sheet microscopy of a human female reproductive tract at 9.5
weeks stained with an antibody to E-cadherin. The mesonephros and Wolffian
ducts (WD) are present. Cranially, the unfused MDs are destined to form the
uterine tubes. Midline fusion of the MDs has created the uterovaginal canal that
terminates caudally by joining the urogenital sinus (UGS).
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mammary rudiments do not disappear, and hence breast development,
lactation (male galactorrhea) and even rarely breast cancer can occur in
men (Giordano, 2018; Tokunaga et al., 1988; Wieland et al., 1967).
Breast cancer is unknown in male mice.
9. Discussion
The validity, relevance and limitations of mouse (and rat) hormone
target organs of male and female reproductive tracts and mammary
glands relative to human development and pathogenesis rests on si-
milarities in anatomy and developmental processes in these species. In
many respects developmental mechanisms are similar, and in many
cases, perhaps identical between humans and mice. Most aspects of
androgen, estrogen and progestin action are shared by both rodents and
humans. For both species masculine urogenital development depends
upon androgens (Cunha et al., 1987). Evidence in mouse, rats and
humans indicates that androgen action elicits prostatic bud formation
and growth, ductal branching morphogenesis and secretory function.
Stabilization and retention of the Wolffian ducts and their subsequent
development into the epididymis, vas deferens and seminal vesicle is
androgen-dependent in all mammalian species examined and mediated
via androgen receptors. The protein hormone, Müllerian inhibiting
substance (also called anti-Müllerian hormone) produced by the fetal
testes elicits destruction of the embryonic Müllerian ducts in mice and
humans. Thus, the basic hormonal mechanisms of sex differentiation
are conserved in both mice and humans, even though the mechanism of
progesterone receptor regulation is entirely different in uterine epi-
thelium of mice and humans as discussed above.
Growth and secretory cytodifferentiation within the female re-
productive tract and mammary glands is stimulated or dependent at
least in part upon estrogenic stimulation, even though initial formation
of female reproductive tract and mammary glands are independent of
estrogen action based upon their development in estrogen receptor
deficient mutant mice (Couse and Korach, 1999a, b). In many tissues
within the female mouse reproductive tract and mammary gland, es-
trogens induce expression of the progesterone receptor as is also the
case in humans. A striking exception is the regulation of the proges-
terone receptor in mouse uterine epithelium in which the progesterone
receptor is highly expressed in the estrogen-deprived state and down
regulated by estrogen (Kurita et al., 2000), a pattern exactly opposite to
that in humans.
The challenge for users of mouse models is to recognize those
anatomic and developmental features in mice that are substantially
different with human development thus requiring caution in extra-
polating mouse studies to human biology, while focusing on those
features that are shared in common. For certain organs developmental
features may be similar/identical to their human counterparts, while
other features within the same organ may exhibit substantial mouse/
human differences. For example, while penile development in both
mice and humans in androgen-dependent, formation of the penile
corporal body is androgen-independent in humans but androgen-de-
pendent in mice (Cunha et al., 2019b).
The degree to which organogenesis in mice differs from that in
humans varies on an organ basis. Clitoral anatomy and development are
completely different in mouse versus human (Cunha et al., 2019a).
Clitoral development is a particularly under reported subject. Studies
on development of the external genitalia have focused mainly on penile
development, perhaps in large part because of experimental models of
mouse hypospadias. To fill this void in the literature, we have dedicated
our companion paper to development of the mouse clitoris, with com-
parison to human clitoral development (Cunha et al., 2019a). Human
and mouse clitoral development proceed via completely different
morphogenetic mechanisms (Baskin et al., 2018; Cunha et al., 2019a;
Overland et al., 2016). Whereas the human clitoris develops directly
from the embryonic genital tubercle (Baskin et al., 2018; Overland
et al., 2016), the U-shaped mouse clitoral lamina, which defines the
mouse clitoris (Martin-Alguacil et al., 2008a; Weiss et al., 2012), de-
rives from the preputial lamina (Cunha et al., 2019a).
Penile development and adult anatomy are likewise different in
mice and humans. While both the mouse and human penis develop
from the genital tubercle, the mouse penis has a fibrocartilaginous
MUMP, an os penis and several additional erectile bodies not present in
the human penis. Formation of the penile urethra occurs via direct
canalization of the urethral plate as well as via epithelial fusion events
in both species, but the spatial readout of these morphogenetic me-
chanisms is exactly opposite in mouse versus human (Liu et al., 2018a).
In humans, epithelial fusion events (fusion of the urethral folds) occurs
in the penile shaft, whereas direct canalization of the urethral plate
occurs within the glans. In mice, urethral plate canalization occurs
proximally within the glans, while epithelial fusion events occur dis-
tally and are involved in formation of the urethral meatus (Baskin et al.,
2018; Liu et al, 2018a, 2018b). It is not surprising that anomalies in-
terpreted as hypospadias in mice bear little resemblance to human
hypospadias (Cunha et al., 2015; Sinclair et al., 2016b).
The therapeutic administration of the synthetic estrogen, diethyl-
stilbestrol (DES), to pregnant women from the mid 1940s to the early
1970s led to the appreciation of estrogens as trans-placental carcino-
gens and teratogens in humans. It also led to a remarkable confluence
between the mouse as an animal model for the deleterious effects in
humans of exogenous estrogens on the developing female reproductive
tract and mammary gland (Bern et al., 1975). The association of pre-
natal DES with clear cell adenocarcinoma of the vagina in young
women (Herbst et al., 1971) coupled with the pioneering studies from
the laboratories of Howard Bern, John McLachlan and John Gunnar
Forsberg revealed a remarkable correspondence between perinatally
estrogen-induced lesions (carcinomatous and teratogenic) in mouse
models and those seen in women exposed prenatally to DES (Bern,
1992; Bern and Talamantes, 1981; Forsberg, 1976; Forsberg and
Kalland, 1981; Herbst and Bern, 1981; Jefferies et al., 1984; Kaufman
and Adam, 2002; Kaufman et al., 1980; McLachlan, 1981; Robboy et al.,
1984a; Titus-Ernstoff et al., 2010). Yet, to this day, no animal model has
ever developed clear-cell vaginal adenocarcinoma. One lesion, cervico-
vaginal adenosis, consisting of simple columnar epithelium and glands
within the vagina, was observed in both perinatally DES-treated mice
and women exposed in utero to DES. Adenosis of the tuboendometrial
type, a benign abnormality of vaginal epithelial differentiation, is
thought to be the substrate from which human clear-cell vaginal ade-
nocarcinoma develops through an intermediate lesion called atypical
adenosis (Robboy et al., 1984b). In mice, DES perturbs the normal
expression of p63 during squamous differentiation of Müllerian vaginal
epithelium leading to the retention of simple columnar p63-negative
adenosis in the vagina (Kurita et al., 2004b). Adenosis has also been
induced experimentally in human fetal vaginas by administration of
DES to host mice bearing grafts of human fetal vagina (Cunha et al.,
2017; Robboy et al., 1982a). Despite the remarkable concurrence be-
tween the mouse and human literature on this subject, it is surprising
that evidence suggests that vaginal epithelial derivation is profoundly
different in mice versus humans (Kurita, 2010; Robboy et al., 2017). In
mice vaginal development culminates in formation of lining epithelium
solely derived from the Müllerian ducts (Kurita, 2010). Studies utilizing
Müllerian duct (PAX2) versus urogenital sinus epithelium (FOXA1)
markers suggest that human vaginal epithelium derives from urogenital
sinus epithelium (Robboy et al., 2017), supporting the earlier findings
of Bulmer (1957). The apparent differences in the derivation of vaginal
epithelium in mice versus humans raises questions regarding the
etiology of vaginal carcinogenesis in these two species.
The Müllerian ducts are the precursors of female internal genitalia
in both mice and humans, and yet many human versus mouse anato-
mical and developmental differences are noted. Midline fusion of the
Müllerian ducts is vastly different in mice versus humans, leading to a
unicornuate uterus in humans and bicornuate uterine horns in mice.
The cervix of mice is lined by a stratified squamous epithelium, while
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the human cervix contains a stratified squamous epithelium in the
exocervix and simple columnar glandular epithelium in the endocervix.
Cervical cancer is a significant health risk in human but is uncommon in
mice. Models of cervical cancer in mice frequently utilize transgenic
mice expressing proteins associated with human papillomavirus (Shai
et al., 2010; Spurgeon et al., 2014). Cervico-vaginal cancer can be in-
duced in mice by perinatal DES (Newbold and McLachlan, 1982). Such
treatment also induces uterine carcinoma (Newbold et al., 1990), which
is rarely seen in untreated mice.
While prostatic development is universally induced by androgens in
all species, significant anatomic and development differences exist in
mouse versus human prostate and prostatic pathology that include: (a)
absence of a ventral prostatic lobe in humans versus the presence of a
ventral prostatic lobe in mice, (b) presence of a thick collagenous
capsule in human prostate and its absence in mice, (c) differences in the
morphology of the verumontanum and associated ducts in human
versus mouse, (d) human/mouse differences in smooth muscle amount
and distribution in so far as prostatic ducts are surrounded by thin
smooth muscle bundles in mouse, whereas smooth muscle is abundant
throughout human prostatic stroma, (e) basal epithelial cells organized
into as a continuous layer in human prostate and a discontinuous layer
in mouse prostate. (f) ductal branching occurring in a mesenchymal
matrix in mice, while ductal branching in human prostate occurs in
both smooth muscle rich and smooth muscle deficient connective
tissue. (g) Squamous metaplasia of prostatic ducts is a common feature
of human prostate in the third trimester and does not occur in mice,
presumably due to the sequestration of serum estrogens by alpha-fe-
toprotein in mice. Spontaneous prostatic hyperplasia and prostatic
carcinoma are rare/absent in mice and very common in humans. The
high incidence of prostatic carcinoma in humans versus the absence of
spontaneous prostatic carcinoma in mice remains to be explained.
The present report highlights the many development and adult
anatomic differences in male and female mouse versus human re-
productive tract development. In this era of genetically engineered mice
used as models of development, differentiation and pathogenesis, it is
critical to be aware of useful and relevant homologies in development
and adult anatomy. More to the point, the investigator should be aware
of significant differences in morphogenesis, development, differentia-
tion and adult anatomy that may render mouse models of questionable
relevance to the human condition.
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